|
[posting]59492781[/posting]9.1. https://www.marketwatch.com/story/akorn-receives-warning-let… => ...Akorn Inc. said Wednesday that it received a warning letter from the Food and Drug Administration, related to an inspection of the generic drug maker's Decatur, Illinois manufacturing facility. The stock was halted for news, and was inactive prior to the halt. The FDA had investigated the facility in April and May 2018. The company said it will respond to the FDA letter, dated Jan. 4, within 15 working days. "Akorn is committed to the highest standards of quality and compliance, and will continue to work collaboratively with the FDA to resolve all issues addressed in the warning letter," Akorn said in a statement... |
|
| aus der Diskussion: | ANALYSE: Akorn-Aktie möglicherweise vor noch größerem Absturz - Raymond James |
| Autor (Datum des Eintrages): | faultcode (09.01.19 14:03:25) |
| Beitrag: | 94 von 146 (ID:59592743) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |